7. Johnson & Johnson (NYSE:JNJ)
Its October 13 third-quarter earnings call provides a near-term catalyst. Investors can examine pharmaceutical growth, MedTech performance, and whether the results support the company’s previously increased annual outlook.
READ THIS: Johnson & Johnson (JNJ) Raised the Bar and Earnings Will Test It
